Growth Metrics

NovoCure (NVCR) Cash from Investing Activities Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -4,224.26%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 95.53%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 3.20%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -18.20%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -208.79%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -187.82%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -397.90%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -514.25%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -211.17%
10 NovoCure 1.90 Bn 1.47 Bn 135.13 Mn 219.70%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 219.70%
Dec 31, 2025 1,614.23%
Sep 30, 2025 600.83%
Jun 30, 2025 109.61%
Mar 31, 2025 -102.63%
Dec 31, 2024 -122.55%
Sep 30, 2024 -40.94%
Jun 30, 2024 -2,594.39%
Mar 31, 2024 199.22%
Dec 31, 2023 176.92%
Sep 30, 2023 111.49%
Jun 30, 2023 -108.92%
Mar 31, 2023 572.64%
Dec 31, 2022 74.34%
Sep 30, 2022 -149.63%
Jun 30, 2022 6,049.47%
Mar 31, 2022 -132.14%
Dec 31, 2021 18.67%
Sep 30, 2021 105.62%
Jun 30, 2021 21.03%
Mar 31, 2021 1,840.71%
Dec 31, 2020 -1,212.43%
Sep 30, 2020 6,871.76%
Jun 30, 2020 -89.65%
Mar 31, 2020 -214.66%
Dec 31, 2019 -2,513.53%
Sep 30, 2019 -116.32%
Jun 30, 2019 -107.60%
Mar 31, 2019 46.74%
Dec 31, 2018 8.07%
Sep 30, 2018 42.64%
Jun 30, 2018 -43.44%
Mar 31, 2018 -114.38%
Dec 31, 2017 42.93%
Sep 30, 2017 60.31%
Jun 30, 2017 91.14%
Mar 31, 2017 -52.95%
Dec 31, 2016 97.29%
Sep 30, 2016 -116.13%
Jun 30, 2016 82.52%
Mar 31, 2016 28.95%
Dec 31, 2015 -1,726.11%